论文部分内容阅读
摘要目的本回顾性研究通过对前瞻性全身MRI扫描进行分析,以评估接受不同化疗方案的病人骨坏死发生率。方法评估42例采用3种化疗方案(6ABVD、2ABVD+4BEACOPP、2ABVD+8BEACOPP)治疗的霍奇金淋巴瘤病人的全身MRI,排除有骨坏死主要危险因素的病人。结果 7例接受8次BEACOPP方案中有6例(86%)、5例接受4次
Abstract Objectives This retrospective study evaluated prospective whole-body MRI scans to assess the incidence of osteonecrosis in patients receiving different chemotherapy regimens. METHODS: Totally 42 patients with Hodgkin’s lymphoma treated with three chemotherapy regimens (6ABVD, 2ABVD + 4BEACOPP, 2ABVD + 8BEACOPP) were evaluated for total body MRI and patients who were excluded for major risk factors for osteonecrosis. Results Of the seven BEACOPP regimens, seven received eight (86%) and five received four